☆ 4.6 Meeting Abstract

Randomized Phase II Study of Pembrolizumab after SBRT versus Pembrolizumab Alone in Patients with Advanced NSCLC, Preliminary Results

JOURNAL OF THORACIC ONCOLOGY (2017)

Journal

JOURNAL OF THORACIC ONCOLOGY

Volume 12, Issue 1, Pages S1453-S1453

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.jtho.2016.11.1983

Keywords

Immunotherapy; NSCLC; SBRT; pembrolizumab

Categories

Oncology Respiratory System

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.